Modelling the Cost Effectiveness of Treatments for Parkinson's Disease: A Methodological Review

Author： Dams Judith  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.12, 2011-12, pp. : 1025-1049

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease: A Review with Methodological Considerations

By Wimo A.  

Drugs & Aging, Vol. 21, Iss. 5, 2004-01 ,pp. : 279-295

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Pharmacotherapies in Early Parkinson's Disease

By Eggert Karla M.   Reese Jens P.   Oertel Wolfgang H.   Dodel Richard  

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 841-860

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Pramipexole in Parkinson's Disease in the US

By Hoerger T.J.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 541-557

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Treatments for Inflammatory Bowel Disease

By Bodger Keith  

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 387-401

Adis International

Access to resources Recommend Favorite

Modelling Disease Progression in Alzheimer's Disease: A Review of Modelling Methods used for Cost-Effectiveness Analysis

By Green Colin  

PharmacoEconomics, Vol. 25, Iss. 9, 2007-01 ,pp. : 735-750

Adis International

Access to resources Recommend Favorite